Japanese Hospital Uses Commercial Stem Cell Treatment in World-First Heart Procedure

A Japanese hospital has performed what a surgeon described as the world’s first implantation of heart muscle cell sheets using a commercially available stem cell treatment.

The procedure involved transplanting sheets of heart muscle cells derived from stem cells. It followed conditional government approval for the treatment’s commercial use.

The announcement marks a step toward bringing stem cell-based heart therapies into clinical practice. The world-first claim concerns the use of a commercially available treatment, rather than the first experimental implantation of such cells.

Details of the patient’s condition and recovery were not provided in the announcement. The conditions attached to the government’s approval were also not specified.